The Central Government’s drive to achieve 20% ethanol blending with petrol by the Ethanol Supply Year (ESY) 2025-26 is impressive, with public sector Oil Marketing Companies (OMCs) already achieving a blending rate of 19.7% in February 2025. For the current ESY (November 1, 2024, to October 31, 2025), the ethanol…
Read More
The share price of Sarthak Metals has come down to Rs 195 and is just 5% over its 52-week low. Sarthak’s share price movement contrasts with the overall market, which is at an all-time high. While there are valid reasons for stock price to have come down, current levels may…
Read More
Sarthak Metal’s core business of supplying certain consumables – cored wires and aluminium flipping coils – for the manufacture of steel continued to suffer headwinds in FY24. For the second year in a row revenue fell, coming down to Rs 305 crore in FY24 as compared to Rs 408 crore…
Read More
The management of Sarthak Metals announced two new areas for expansion in 2023. The backdrop to this is: the management was evaluating options for expansion for some time. In its main business of making two key consumables for manufacture of steel – cored wire and aluminium flipping coils – the…
Read More
Indrayani Biotech (BSE: 526445) is a growth stock that is likely to show strong double digit growth over the next few years. In its Annual Report released the last week, the company has projected a consolidated revenue of Rs 150 crore for FY23. In comparison, the revenue for FY22 was Rs…
Read More
2022 is witnessing a sharp drop in global biotech investments by venture capital funds. Data compiled by Wisdomsmith shows venture capital funds invested $15.8B in biotech and healthcare sector over Jan-Apr’22, as compared to $27B over the same period in 2021. That’s a drop of 41%. While the drop…
Read More We recorded 79 VC/PE transactions pertaining to the global life sciences sector for September 2021, aggregating to a sum of USD 3.3B, as against 96 transactions and USD5.6B in Sep’20. The USA recorded 49 transactions aggregating to a total investment of USD 2.2B. China reported a totally out of character…
Read More We recorded 114 VC/PE transactions pertaining to the global life sciences sector for June 2021, aggregating to a sum of USD 6.47B. The USA recorded 69 transactions aggregating to a total investment of USD 3.26B. China reported investment of USD 886m from 11 VC/PE transactions. Rest of the world accounted…
Read More We recorded 94 VC/PE transactions pertaining to the global life sciences sector for May 2021, aggregating to a sum of USD 6.56B. The USA recorded 60 transactions aggregating to a total investment of USD 3.3B. China reported investment of USD 1.8B from 12 VC/PE transactions. Rest of the world accounted…
Read More We recorded 131 VC/PE transactions pertaining to the global life sciences sector for April 2021, aggregating to a sum of USD 6.5B. The USA recorded 88 transactions with total investment of USD 3.8B. China reported investment of USD 585m from 12 VC/PE transactions. Rest of world accounted for 31 transactions…
Read More